(Q43604506)

English

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function (English)

1 reference

Europe PubMed Central

25 November 2017

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

B Pitt

1

1 reference

Europe PubMed Central

25 November 2017

B O'Neill

2

1 reference

Europe PubMed Central

25 November 2017

R Feldman

3

1 reference

Europe PubMed Central

25 November 2017

R Ferrari

4

1 reference

Europe PubMed Central

25 November 2017

L Schwartz

5

1 reference

Europe PubMed Central

25 November 2017

H Mudra

6

1 reference

Europe PubMed Central

25 November 2017

T Bass

7

1 reference

Europe PubMed Central

25 November 2017

C Pepine

8

1 reference

Europe PubMed Central

25 November 2017

M Texter

9

1 reference

Europe PubMed Central

25 November 2017

H Haber

10

1 reference

Europe PubMed Central

25 November 2017

A Uprichard

11

1 reference

Europe PubMed Central

25 November 2017

L Cashin-Hemphill

12

1 reference

Europe PubMed Central

25 November 2017

R S Lees

13

1 reference

Europe PubMed Central

25 November 2017

QUIET Study Group

14

1 reference

Europe PubMed Central

25 November 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

25 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

25 November 2017

87

1 reference

Europe PubMed Central

25 November 2017

9

1 reference

Europe PubMed Central

25 November 2017

1058-1063

1 reference

Europe PubMed Central

25 November 2017

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Prognostic significance of progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Vascular affinity of trandolapril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Ongoing clinical trials of angiotensin-converting enzyme inhibitors for treatment of coronary artery disease in patients with preserved left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901461-8

7 January 2021

Identifiers

10.1016/S0002-9149(01)01461-8

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43604506&oldid=2101849188"